Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition • 09-14 May 2026
|
468-01-001.
Microstructure Matters: DRTT Tract Quality as a Biomarker of VIM-DBS Response in Essential Tremor
Impact: Presurgical
diffusion and MVF markers in the DRTT show strong relations with VIM-DBS tremor
improvement, independent of disease duration. Embedding these
microstructural/myelin relations into planning can personalize targeting,
standardize outcomes, and enable decision support for tremor surgery.
|
||
|
468-01-002.
Assessing Brain Mechanical Anisotropy in Amyotrophic Lateral Sclerosis with MR elastography
Impact: TWE-NITI anisotropic MRE reveals ALS-related reductions in brain stiffness and mechanical anisotropy, notably in the inferior corpus callosum. All aspects of mechanical anisotropy decline in ALS, suggesting anisotropic MRE could serve as a sensitive longitudinal clinical microstructural biomarker.
|
||
|
468-01-003.
Non-invasive microstructural characterization of Iron Overload in Aceruloplasminemia patients
Impact: This study shows that not only the amount of iron but also its microstructural distribution determine relaxation in tissue. Relaxometry combined with theoretical modelling provides deeper microstructural insight into neurodegenerative iron pathology in Aceruloplasminemia (ACP).
|
||
|
468-01-004.
Quantitative MRI assessment of cerebellar neurodegeneration and metabolic alterations in Lafora disease
Impact: This study reveals undetected cerebellar
neurodegenerative alterations in Lafora disease through advanced quantitative
MRI, highlighting iron accumulation and neuronal loss, and offering new
insights into the disease’s pathophysiology beyond conventional imaging
approaches.
|
||
|
468-01-005.
Imaging–Transcriptomic Decoding of Cortical Reorganization in SCA3 Using MIND Networks
Impact: Cortical reorganization in SCA3 aligns with spatial gene-expression gradients. Using MIND networks from MRI plus AHBA-based imaging transcriptomics, we identify metabolic/ECM/vascular pathways and glial–endothelial signatures linked to regional morphometric disruption, nominating biologically grounded imaging markers for future trials.
|
||
|
468-01-006.
Simultaneous Dynamic Sodium MRI-EEG with Dual-VENC Quantification of CSF Flow Velocity During Human Sleep
Impact: Findings highlight disrupted CSF
pulsation in Alzheimer’s disease and demonstrate that dynamic ²³Na MRI–EEG can
probe sleep-related brain-clearance pathways, opening new avenues to study
vascular health, CSF Clearence, glymphatic impairment, and potential
interventions improving waste removal in neurodegeneration.
|
||
|
468-01-007.
White Matter Microstructural Alterations in Multi-System Atrophy Revealed by Multi-Model Diffusion TBSS
Impact: This
systematic assessment of white matter microstructural changes in MSA patients
not only enhances our understanding of the disease pathology but also offers
valuable imaging-based evidence for patient stratification and treatment
evaluation.
|
||
|
468-01-008.
Trial-Ready Power Estimates for Longitudinal Resting-state fMRI Biomarkers in ALS
Impact: Trial-ready power estimates demonstrate that rs-fMRI functional connectivity can detect longitudinal ALS-related change with as few as 11 participants per group in a one-year trial, while shorter trials substantially inflate sample size, informing efficient design of emerging molecular therapy studies.
|
||
|
468-01-009.
MRI-Derived OEF and BBB Permeability Correlate with Neurological Severity in Wilson’s Disease
Impact: We demonstrate for the first time in Wilson’s disease that vascular insufficiency and blood–brain barrier disruption, detected by multimodal quantitative MRI, correlate with neurological severity, establishing novel biomarkers for noninvasive monitoring disease progression, and for evaluating chelation or vascular-targeted therapies.
|
||
|
468-01-010.
Sub-voxel QSM Reveals Differential Iron and Myelin Pathology in Pre-diabetes and T2DM Cognitive Dysfunction
Impact: This study provides novel
insights into the changes of iron and myelin pathology in diabetes-related
cognitive impairment, highlighting unique early myelin alterations in the
pre-diabetic stage.
|
||
|
468-01-011.
Elevated Oxygen Extraction in Type 2 Diabetes: Early Cerebral Metabolic Changes in Cognition-Related Brain Regions
Impact: This study identifies elevated brain oxygen extraction fraction (OEF) in Type 2 Diabetes Mellitus as an early marker of cerebral metabolic dysfunction, enabling earlier detection of diabetes-related cognitive risk and guiding clinicians toward targeted interventions before structural brain damage occurs
|
||
|
468-01-012.
Normative references for amygdala subregions across the lifespan and heterogeneous alterations in neurological diseases.
Impact: Our
study established the first large-sample normative references for the amygdala
and its subregion volumes, and applied it to a variety of neurological
diseases, which can fill the gap in standardized references for fine structural
research and facilitate clinical translations.
|
||
|
468-01-013.
A WEPCAST-based Investigation: Blood-Brain Barrier Permeability and Cognitive Impairment in Type 1 Narcolepsy
Impact: Neuroinflammation may mediate a significant increase in blood-brain barrier (BBB) permeability in Type 1 Narcolepsy (NT1), potentially representing a key mechanism underlying cognitive impairment in these patients.
|
||
|
468-01-014.
Early and dynamic changes in MRI-based morphometry of the cervical spinal cord in spinocerebellar ataxia type 1
Impact: Spinal
cord imaging, especially at C2, emerges as an early and dynamic biomarker for
SCA1. This shows its potential use for patient stratification, monitoring of
progression, and potentially as an outcome measure in preventive trials.
|
||
|
468-01-015.
Frontal glutathione quantified with MRS: Relationship to perioperative neurocognitive changes in elderly patients
Impact: The glutathione (GSH) levels of the medial prefrontal cortex (mPFC) in elderly patients undergoing total knee arthroplasty under intrathecal anesthesia may be related to perioperative parameters of executive functional changes.
|
||
|
468-01-016.
Higher fasting brain glucose is associated with lower gray matter volume in healthy adults
Impact: Brain glucose measured by ¹H MRS identifies metabolic dysfunction before symptoms appear, enabling early intervention. These findings redirect focus from peripheral glucose management to
brain-specific therapies targeting neural insulin sensitivity and
alternative fuel utilization, guiding neuroprotective strategies for
age-related neurodegeneration.
|
© 2026 International Society for Magnetic Resonance in Medicine